Endometriosis Treatment Drugs Prescription Analysis

Endometriosis Treatment Market: Launch of Novel GnRH Analogues Anticipated to Substitute Oral Contraceptive Prescriptions: Global Industry Analysis 2013-2017 and Opportunity Assessment 2018-2028

  • 222 pages
  • PDF PPT EXCEL
Endometriosis Treatment Drugs Prescription Analysis
  • SELECT LICENSE :

  • US$5,000
  • US$7,500
  • US$10,000

Endometriosis Treatment – Increased Awareness among People and Growing Treatment-Seeking Rate

Increasing awareness among the general population as well as physicians regarding endometriosis, and the increasing diagnosis rate and treatment-seeking rate for endometriosis conditions are among factors expected to boost the endometriosis treatment market. Companies are coming up with major branding, launching new products, and reducing the costs of their product offerings to reach out to people who are likely to be suffering from endometriosis conditions.

Endometriosis Market Set to Grow by 1.3X between 2018 and 2028

Product diversification in different economies, growing adoption of other alternative treatment for the condition which continue to augur well for the Endometriosis Treatment landscape. Great opportunity for the manufactures to involve in the awareness campaigns, public events and collaboration with the government and other organisations which is expected to fuel the Endometriosis Treatment market.

Stakeholders Vie to Tap Opportune Potential of Emerging Markets

Growing prevalence of Endometriosis condition and need for generic drugs and personalized treatment in emerging markets is expected to create huge opportunity for the manufacturer. Western Europe continues to lead the endometriosis treatment landscape, with sales growing at a relatively higher rate.

* This data is only a representation. Actual data may vary and will be available in report.

Stakeholders Vie to Tap Opportune Potential of Emerging Markets
Stakeholders Vie to Tap Opportune Potential of Emerging Markets
Stakeholders Vie to Tap Opportune Potential of Emerging Markets
Stakeholders Vie to Tap Opportune Potential of Emerging Markets
  • 2014
  • 2018
  • 2022
  • 2028
  • Arrow

The Broader Perspective

The manufacturers of endometriosis treatment products are focusing on increasing their market share in the Asia Pacific region through mergers and acquisitions with regional or local players as well as investment groups. In addition, manufacturers are focusing on forward integration with partnerships with wholesalers, distributors, and other channel partners to gain ownership over the value chain.

Oral contraceptives remain the top-selling variant with a share of over 45%.

The sales of GnRH analogues are expected to grow at a higher rate among other drug types

Adoption of the LNR-IUDs drug type is expected to remain low during the forecast period.

Hormonal therapy remains the most lucrative category, accounting for a market share of over 80%.

Pain management is likely to witness slow growth.

Hospital pharmacies continue to lead the endometriosis treatment landscape due to an increasing treatment-seeking rate, especially in developed countries.

Retail pharmacies also account for a notable share of the market.

Demand is expected to grow at a significant rate in the e-commerce segment.

How Growth will Unfold

Oral contraceptives are expected to account for a leading share of the endometriosis treatment market by drug type, owing to their high adoption, coupled with the increasing incidence of chronic conditions and the availability of limited treatment options. The development of novel hormonal therapies due to the higher benefits offered by pain management medications is expected to fuel the growth of the endometriosis treatment market.

Hospital Pharmacies | Retail Pharmacies | Drugstores | E-commerce

* This data is only a representation. Actual data may vary and will be available in report.

Click Here To Know How The Growth Will Unfold

Read in-depth analysis on Endometriosis Treatment Drugs Prescription Analysis

Overview

Endometriosis Treatment Market: Global Industry Analysis 2013-2017 and Opportunity Assessment 2018-2028

A recent market study published by FMI “Endometriosis Treatment Market: Global Industry Analysis 2013–2017 and Forecast 2018–2028” offers a comprehensive assessment of the most important market dynamics. After conducting thorough research on the historic as well as current growth parameters of the endometriosis treatment market, the growth prospects of the market are obtained with maximum precision.

Endometriosis Treatment Market Taxonomy

The global endometriosis treatment market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach in front of the reader.

By Drug Type

  • Oral Contraceptives
  • Progestin
  • Non-steroidal anti-inflammatory drugs (NSAIDs)
  • GnRH Analogues
  • LNR-IUDs
  • Others

By Treatment Type

  • Hormonal Therapy
  • Pain management

By Distribution Channel

  • Hospital pharmacies,
  • Retail pharmacies,
  • Drugstores
  • E-commerce

Region

  • North America
  • Latin America
  • Eastern Europe
  • Western Europe
  • APEC
  • China
  • Middle East & Africa

What's Included

The report commences with the executive summary of the endometriosis treatment market report, which includes a summary of the key findings and key statistics of the market. It also includes the market value (US$ million) for leading segments in the endometriosis treatment market.

Readers can find a detailed market structure and definition of endometriosis treatment and drug types, in this chapter, which helps in understanding the basic information about the endometriosis treatment market. The definition section considers the factors included and excluded for the purpose of this report.

Readers can find the outlook of the global endometriosis treatment market, considering various factors associated with the growth, which would help in tracking the market’s current scenario, with key inferences drawn from historical data, current trends, and future prospects. Macro-economic factors influencing the market are also discussed in this segment. A brief understanding of the global healthcare sector is also provided in this section.

This chapter highlights the key market dynamics, including drivers, restraints, opportunities, and trends. In this chapter, readers can understand factors that are propelling the growth of the market, along with factors that may deter the growth of the market. Also, readers will understand the key trends followed by leading manufacturers in the endometriosis treatment market.

Key pointers such as pipeline drug analysis and new medical treatments for endometriosis are also included in this endometriosis treatment market report.

This chapter includes detailed analysis of the growth of the North America endometriosis treatment market, along with a country-wise assessment of the U.S. and Canada. Readers can also find historical trends and market attractiveness based on drug type, treatment type, distribution channel, and country in the North American region.

This chapter includes detailed analysis of the growth of the Latin America endometriosis treatment market, along with a country-wise assessment, including Brazil and Mexico. Market attractiveness based on various segments is provided for the Latin American region.

Important growth prospects of the endometriosis treatment market can be found with market attractiveness based on drug type, treatment type, and distribution channel. European countries such as Germany, France, Italy, Spain, and the U.K. are included in this chapter for industry analysis.

 

This chapter includes detailed analysis of the growth of the Eastern Europe endometriosis treatment market, along with a country-wise assessment, including Russia and Poland. Market attractiveness based on various segments is provided for the Eastern European region.

 

India, Australia & New Zealand, and Japan are the leading countries/regions in the Asia Pacific region that are assessed to obtain the growth prospects of the APEC endometriosis treatment market in this chapter. Readers can find thorough information about the growth parameters. Market attractiveness based drug type, treatment type, and distribution channel for endometriosis treatment in the APEC region is also provided in this section.

This chapter includes detailed analysis of the growth of the China endometriosis treatment market. Market attractiveness based drug type, treatment type, and distribution channel is present for this region

This chapter provides information on how the endometriosis treatment market will grow in major countries of the MEA region, such as GCC Countries and South Africa, during the period 2018-2028.

This chapter provides forecast factors for relevance in building the market value for the endometriosis treatment market

This chapter includes a comprehensive list of all the leading manufacturers in the endometriosis treatment market, along with detailed information about each company, including company overview, revenue share, strategic overview, and recent company developments. Market players featured in the report include AbbVie Inc., Bayer AG, AstraZeneca, Pfizer Inc., Teva Pharmaceutical Industries Ltd., Ipsen Pharma, Myovant Sciences Ltd, Endoceutics, Inc., Debiopharm Group and Mayne Pharma Group Limited

This section highlights endometriosis treatment in the overall global market by value (US$ Mn) forecast and analysis, by region.

Based on drug type market analysis, the endometriosis treatment market is segmented into oral contraceptives, progestins, NSAIDs, GnRH analogues, LNR-IUDs, and others.

Based on distribution channel, the endometriosis treatment market is segmented into hospital pharmacies, retail pharmacies, drugstores, and e-Commerce.

This section highlights the overall global market value (US$ Mn) forecast and analysis of the endometriosis treatment market, with detailed incremental opportunity and absolute opportunity.

This section consists of a glossary of the assumptions and acronyms used in the endometriosis treatment market report.

This chapter helps readers understand the research methodology that is followed to obtain various conclusions, important qualitative information, and quantitative information about the endometriosis treatment market.

How the research was conducted?

Primary Research

Primary research interview with Key Opinion Leaders and other participants were conducted for data collection and validation of the below information:

  • High Prevalence by Gender and Age-Group
  • Treatment Seeking Rate
  • Adoption of Non-steroidal anti-inflammatory drugs injection as mode of treatment
  • Average Dosage Pattern per Patient
  • Average Selling Price (US$) and Market Growth
  • Key Developments
  • Key Trends and Opportunities
  • Regional wise Dynamics
  • Reimbursement Landscape
  • Market Share Information
  • Key Brands
  • Competition & Key Vendor Strategies

Secondary Research

  • Jean Hailes
  • endometriosis.org
  • Endometriosis UK,
  • womenshealth.gov
  • American College of Obstetricians and Gynecologists
  • Endometriosis Australia
  • ENDOMETRIOSIS FOUNDATION OF AMERICA
  • American Pregnancy Association
  • National Institute of Child Health and Human Development
  • The National Women’s Health Information Center
  • Royal College of Obstetricians and Gynecologists
  • Endometriosis Association, Inc.
  • Boston Center for Endometriosis
  • Endometriosis Research Center
  • American Society for Reproductive Medicine
  • National Women’s health Network (NWHN)
  • Society of Endometriosis and Uterine Disorders
  • Endometriosis New Zealand Ltd.
  • Annual Reports/SEC filings/Investor Presentations/Earning Call Transcript
  • Industry Journals

Primary Interview Splits

Primary Research Interview Splits

Endometriosis Treatment Market Reports - Table of Contents

  1. Global Overview of Clinical Trails, by Region

  2. Clinical trials of cytotoxics as reported, by Phase

  3. Reported number of study type for each clinical trial

  4. North America Endometriosis Treatment Market Share, By Drug Type, 2018

  5. North America Endometriosis Treatment Market Share, By Treatment Type, 2018

  6. North America Endometriosis Treatment Market Share, By Distribution Channel, 2018

  7. North America Endometriosis Treatment Market Share, By Country, 2018

  8. North America Endometriosis Treatment Market Value US$

  9. North America Endometriosis Treatment Market size (US$ Mn) Analysis, 2013–2017

  10. North America Endometriosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028

  11. US Endometriosis Treatment Market Size (US$ Mn) Analysis, 2013–2017

  12. US Endometriosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028

  13. Canada Endometriosis Treatment Market Size (US$ Mn) Analysis, 2013–2017

  14. Canada Endometriosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028

  15. North America Endometriosis Treatment Market Size (US$ Mn) Analysis, 2013–2017, Oral Contraceptives

  16. North America Endometriosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, Oral Contraceptives

  17. North America Endometriosis Treatment Market Size (US$ Mn) Analysis, 2013–2017, Progestins

  18. North America Endometriosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, Progestins

  19. North America Endometriosis Treatment Market Size (US$ Mn) Analysis, 2013–2017, NSAIDs

  20. North America Endometriosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, NSAIDs

  21. North America Endometriosis Treatment Market Size (US$ Mn) Analysis, 2013–2017, GnRH Analogues

  22. North America Endometriosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, GnRH Analogues

  23. North America Endometriosis Treatment Market Size (US$ Mn) Analysis, 2013–2017, LNR-IUDs

  24. North America Endometriosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, LNR-IUDs

  25. North America Endometriosis Treatment Market Size (US$ Mn) Analysis, 2013–2017, Others

  26. North America Endometriosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, Others

  27. North America Endometriosis Treatment Market Attractiveness Analysis, By Drug Type

  28. North America Endometriosis Treatment Market Attractiveness Analysis, By Treatment Type

  29. North America Endometriosis Treatment Market Attractiveness Analysis, By Distribution Channel

  30. North America Endometriosis Treatment Market Attractiveness Analysis, By Country

  31. Latin America Endometriosis Treatment Market Share, By Drug Type, 2018

  32. Latin America Endometriosis Treatment Market Share, By Treatment Type, 2018

  33. Latin America Endometriosis Treatment Market Share, By Distribution Channel, 2018

  34. Latin America Endometriosis Treatment Market Share, By Country, 2018

  35. Latin America Endometriosis Treatment Market Value US$

  36. Latin America Endometriosis Treatment Market size (US$ Mn) Analysis, 2013–2017

  37. Latin America Endometriosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028

  38. Brazil Endometriosis Treatment Market Size (US$ Mn) Analysis, 2013–2017

  39. Brazil Endometriosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028

  40. Mexico Endometriosis Treatment Market Size (US$ Mn) Analysis, 2013–2017

  41. Mexico Endometriosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028

  42. Rest of Latin America Endometriosis Treatment Market Size (US$ Mn) Analysis, 2013–2017

  43. Rest of Latin America Endometriosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028

  44. Latin America Endometriosis Treatment Market Size (US$ Mn) Analysis, 2013–2017, Oral Contraceptives

  45. Latin America Endometriosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, Oral Contraceptives

  46. Latin America Endometriosis Treatment Market Size (US$ Mn) Analysis, 2013–2017, Progestins

  47. Latin America Endometriosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, Progestins

  48. Latin America Endometriosis Treatment Market Size (US$ Mn) Analysis, 2013–2017, NSAIDs

  49. Latin America Endometriosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, NSAIDs

  50. Latin America Endometriosis Treatment Market Size (US$ Mn) Analysis, 2013–2017, GnRH Analogues

  51. Latin America Endometriosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, GnRH Analogues

  52. Latin America Endometriosis Treatment Market Size (US$ Mn) Analysis, 2013–2017, LNR-IUDs

  53. Latin America Endometriosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, LNR-IUDs

  54. Latin America Endometriosis Treatment Market Size (US$ Mn) Analysis, 2013–2017, Others

  55. Latin America Endometriosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, Others

  56. Latin America Endometriosis Treatment Market Attractiveness Analysis, By Drug Type

  57. Latin America Endometriosis Treatment Market Attractiveness Analysis, By Treatment Type

  58. Latin America Endometriosis Treatment Market Attractiveness Analysis, By Distribution Channel

  59. Latin America Endometriosis Treatment Market Attractiveness Analysis, By Country

  60. Western Europe Endometriosis Treatment Market Share, By Drug Type, 2018

  61. Western Europe Endometriosis Treatment Market Share, By Treatment Type, 2018

  62. Western Europe Endometriosis Treatment Market Share, By Distribution Channel, 2018

  63. Western Europe Endometriosis Treatment Market Share, By Country, 2018

  64. Western Europe Endometriosis Treatment Market Value US$

  65. Western Europe Endometriosis Treatment Market size (US$ Mn) Analysis, 2013–2017

  66. Western Europe Endometriosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028

  67. U.K Endometriosis Treatment Market Size (US$ Mn) Analysis, 2013–2017

  68. U.K Endometriosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028

  69. Germany Endometriosis Treatment Market Size (US$ Mn) Analysis, 2013–2017

  70. Germany Endometriosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028

  71. Spain Endometriosis Treatment Market Size (US$ Mn) Analysis, 2013–2017

  72. Spain Endometriosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028

  73. Italy Endometriosis Treatment Market Size (US$ Mn) Analysis, 2013–2017

  74. Italy Endometriosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028

  75. France Endometriosis Treatment Market Size (US$ Mn) Analysis, 2013–2017

  76. France Endometriosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028

  77. Rest of Western Europe Endometriosis Treatment Market Size (US$ Mn) Analysis, 2013–2017

  78. Rest of Western Europe Endometriosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028

  79. Western Europe Endometriosis Treatment Market Size (US$ Mn) Analysis, 2013–2017, Oral Contraceptives

  80. Western Europe Endometriosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, Oral Contraceptives

  81. Western Europe Endometriosis Treatment Market Size (US$ Mn) Analysis, 2013–2017, Progestins

  82. Western Europe Endometriosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, Progestins

  83. Western Europe Endometriosis Treatment Market Size (US$ Mn) Analysis, 2013–2017, NSAIDs

  84. Western Europe Endometriosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, NSAIDs

  85. Western Europe Endometriosis Treatment Market Size (US$ Mn) Analysis, 2013–2017, GnRH Analogues

  86. Western Europe Endometriosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, GnRH Analogues

  87. Western Europe Endometriosis Treatment Market Size (US$ Mn) Analysis, 2013–2017, LNR-IUDs

  88. Western Europe Endometriosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, LNR-IUDs

  89. Western Europe Endometriosis Treatment Market Size (US$ Mn) Analysis, 2013–2017, Others

  90. Western Europe Endometriosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, Others

  91. Western Europe Endometriosis Treatment Market Attractiveness Analysis, By Drug Type

  92. Western Europe Endometriosis Treatment Market Attractiveness Analysis, By Treatment Type

  93. Western Europe Endometriosis Treatment Market Attractiveness Analysis, By Distribution Channel

  94. Western Europe Endometriosis Treatment Market Attractiveness Analysis, By Country

  95. Eastern Europe Endometriosis Treatment Market Share, By Drug Type, 2018

  96. Eastern Europe Endometriosis Treatment Market Share, By Treatment Type, 2018

  97. Eastern Europe Endometriosis Treatment Market Share, By Distribution Channel, 2018

  98. Eastern Europe Endometriosis Treatment Market Share, By Country, 2018

  99. Eastern Europe Endometriosis Treatment Market Value US$

  100. Eastern Europe Endometriosis Treatment Market size (US$ Mn) Analysis, 2013–2017

  101. Eastern Europe Endometriosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028

  102. Russia Endometriosis Treatment Market Size (US$ Mn) Analysis, 2013–2017

  103. Russia Endometriosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028

  104. Poland Endometriosis Treatment Market Size (US$ Mn) Analysis, 2013–2017

  105. Poland Endometriosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028

  106. Rest of Eastern Europe Endometriosis Treatment Market Size (US$ Mn) Analysis, 2013–2017

  107. Rest of Eastern Europe Endometriosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028

  108. Eastern Europe Endometriosis Treatment Market Size (US$ Mn) Analysis, 2013–2017, Oral Contraceptives

  109. Eastern Europe Endometriosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, Oral Contraceptives

  110. Eastern Europe Endometriosis Treatment Market Size (US$ Mn) Analysis, 2013–2017, Progestins

  111. Eastern Europe Endometriosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, Progestins

  112. Eastern Europe Endometriosis Treatment Market Size (US$ Mn) Analysis, 2013–2017, NSAIDs

  113. Eastern Europe Endometriosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, NSAIDs

  114. Eastern Europe Endometriosis Treatment Market Size (US$ Mn) Analysis, 2013–2017, GnRH Analogues

  115. Eastern Europe Endometriosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, GnRH Analogues

  116. Eastern Europe Endometriosis Treatment Market Size (US$ Mn) Analysis, 2013–2017, LNR-IUDs

  117. Eastern Europe Endometriosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, LNR-IUDs

  118. Eastern Europe Endometriosis Treatment Market Size (US$ Mn) Analysis, 2013–2017, Others

  119. Eastern Europe Endometriosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, Others

  120. Eastern Europe Endometriosis Treatment Market Attractiveness Analysis, By Drug Type

  121. Eastern Europe Endometriosis Treatment Market Attractiveness Analysis, By Treatment Type

  122. Eastern Europe Endometriosis Treatment Market Attractiveness Analysis, By Distribution Channel

  123. Eastern Europe Endometriosis Treatment Market Attractiveness Analysis, By Country

  124. APEC Endometriosis Treatment Market Share, By Drug Type, 2018

  125. APEC Endometriosis Treatment Market Share, By Treatment Type, 2018

  126. APEC Endometriosis Treatment Market Share, By Distribution Channel, 2018

  127. APEC Endometriosis Treatment Market Share, By Country, 2018

  128. APEC Endometriosis Treatment Market Value US$

  129. APEC Endometriosis Treatment Market size (US$ Mn) Analysis, 2013–2017

  130. APEC Endometriosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028

  131. India Endometriosis Treatment Market Size (US$ Mn) Analysis, 2013–2017

  132. India Endometriosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028

  133. Australia & NZ Endometriosis Treatment Market Size (US$ Mn) Analysis, 2013–2017

  134. Australia & NZ Endometriosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028

  135. Japan Endometriosis Treatment Market Size (US$ Mn) Analysis, 2013–2017

  136. Japan Endometriosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028

  137. Rest of APEC Endometriosis Treatment Market Size (US$ Mn) Analysis, 2013–2017

  138. Rest of APEC Endometriosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028

  139. APEC Endometriosis Treatment Market Size (US$ Mn) Analysis, 2013–2017, Oral Contraceptives

  140. APEC Endometriosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, Oral Contraceptives

  141. APEC Endometriosis Treatment Market Size (US$ Mn) Analysis, 2013–2017, Progestins

  142. APEC Endometriosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, Progestins

  143. APEC Endometriosis Treatment Market Size (US$ Mn) Analysis, 2013–2017, NSAIDs

  144. APEC Endometriosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, NSAIDs

  145. APEC Endometriosis Treatment Market Size (US$ Mn) Analysis, 2013–2017, GnRH Analogues

  146. APEC Endometriosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, GnRH Analogues

  147. APEC Endometriosis Treatment Market Size (US$ Mn) Analysis, 2013–2017, LNR-IUDs

  148. APEC Endometriosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, LNR-IUDs

  149. APEC Endometriosis Treatment Market Size (US$ Mn) Analysis, 2013–2017, Others

  150. APEC Endometriosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, Others

  151. APEC Endometriosis Treatment Market Attractiveness Analysis, By Drug Type

  152. APEC Endometriosis Treatment Market Attractiveness Analysis, By Treatment Type

  153. APEC Endometriosis Treatment Market Attractiveness Analysis, By Distribution Channel

  154. APEC Endometriosis Treatment Market Attractiveness Analysis, By Country

  155. China Endometriosis Treatment Market Share, By Drug Type, 2018

  156. China Endometriosis Treatment Market Share, By Treatment Type, 2018

  157. China Endometriosis Treatment Market Share, By Distribution Channel, 2018

  158. China Endometriosis Treatment Market Value US$

  159. China Endometriosis Treatment Market size (US$ Mn) Analysis, 2013–2017

  160. China Endometriosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028

  161. China Endometriosis Treatment Market Size (US$ Mn) Analysis, 2013–2017, Oral Contraceptives

  162. China Endometriosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, Oral Contraceptives

  163. China Endometriosis Treatment Market Size (US$ Mn) Analysis, 2013–2017, Progestins

  164. China Endometriosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, Progestins

  165. China Endometriosis Treatment Market Size (US$ Mn) Analysis, 2013–2017, NSAIDs

  166. China Endometriosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, NSAIDs

  167. China Endometriosis Treatment Market Size (US$ Mn) Analysis, 2013–2017, GnRH Analogues

  168. China Endometriosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, GnRH Analogues

  169. China Endometriosis Treatment Market Size (US$ Mn) Analysis, 2013–2017, LNR-IUDs

  170. China Endometriosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, LNR-IUDs

  171. China Endometriosis Treatment Market Size (US$ Mn) Analysis, 2013–2017, Others

  172. China Endometriosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, Others

  173. China Endometriosis Treatment Market Attractiveness Analysis, By Treatment Type

  174. China Endometriosis Treatment Market Attractiveness Analysis, By Distribution Channel

  175. China Endometriosis Treatment Market Attractiveness Analysis, By Drug Type

  176. MEA Endometriosis Treatment Market Share, By Drug Type, 2018

  177. MEA Endometriosis Treatment Market Share, By Treatment Type, 2018

  178. MEA Endometriosis Treatment Market Share, By Distribution Channel, 2018

  179. MEA Endometriosis Treatment Market Share, By Country, 2018

  180. MEA Endometriosis Treatment Market Value US$

  181. MEA Endometriosis Treatment Market size (US$ Mn) Analysis, 2013–2017

  182. MEA Endometriosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028

  183. South Africa Endometriosis Treatment Market Size (US$ Mn) Analysis, 2013–2017

  184. South Africa Endometriosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028

  185. GCC Countries Endometriosis Treatment Market Size (US$ Mn) Analysis, 2013–2017

  186. GCC Countries Endometriosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028

  187. Rest of MEA Endometriosis Treatment Market Size (US$ Mn) Analysis, 2013–2017

  188. Rest of MEA Endometriosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028

  189. MEA Endometriosis Treatment Market Size (US$ Mn) Analysis, 2013–2017, Oral Contraceptives

  190. MEA Endometriosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, Oral Contraceptives

  191. MEA Endometriosis Treatment Market Size (US$ Mn) Analysis, 2013–2017, Progestins

  192. MEA Endometriosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, Progestins

  193. MEA Endometriosis Treatment Market Size (US$ Mn) Analysis, 2013–2017, NSAIDs

  194. MEA Endometriosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, NSAIDs

  195. MEA Endometriosis Treatment Market Size (US$ Mn) Analysis, 2013–2017, GnRH Analogues

  196. MEA Endometriosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, GnRH Analogues

  197. MEA Endometriosis Treatment Market Size (US$ Mn) Analysis, 2013–2017, LNR-IUDs

  198. MEA Endometriosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, LNR-IUDs

  199. MEA Endometriosis Treatment Market Size (US$ Mn) Analysis, 2013–2017, Others

  200. MEA Endometriosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, Others

  201. MEA Endometriosis Treatment Market Attractiveness Analysis, By Drug Type

  202. MEA Endometriosis Treatment Market Attractiveness Analysis, By Treatment Type

  203. MEA Endometriosis Treatment Market Attractiveness Analysis, By Distribution Channel

  204. MEA Endometriosis Treatment Market Attractiveness Analysis, By Country

  205. Global Endometriosis Treatment Market value Share, By Region, 2018-2028

  206. Global Endometriosis Treatment Market Y-o-Y Growth (%), , By Region, 2017-2028

  207. Global Endometriosis Treatment Market Attractiveness Analysis, By Region

  208. Global Endometriosis Treatment Market value Share, By Drug Type, 2018-2028

  209. Global Endometriosis Treatment Market Attractiveness Analysis, By Drug Type

  210. Global Endometriosis Treatment Market Analysis, By Treatment Type

  211. Global Endometriosis Treatment Market Attractiveness Analysis, By Treatment Type

  212. Global Endometriosis Treatment Market value share, By Distribution Channel. 2018-2028

  213. Global Endometriosis Treatment Market Attractiveness Analysis, By Distribution Channel

  214. Global Endometriosis Treatment Industry Value Analysis US$ 2017-2028

  215. Global Endometriosis Treatment Market Absolute $ Opportunity (US$ Mn), 2013–2017

  216. Global Endometriosis Treatment Market Absolute $ Opportunity (US$ Mn), 2017–2028

  1. Expenditure on Health, (% of GDP), by Country, 2016 - 2021

  2. Expenditure on Health, (% of GDP), by Country, 2016 - 2021

  3. New medical treatment of endometriosis.

  4. Potential diagnostic biomarkers for endometriosis

  5. North America Endometriosis Treatment Market size (US$ Mn) Analysis 2013–2017 and Opportunity Assessment 2018–2028, By Country

  6. North America Endometriosis Treatment Market size (US$ Mn) Analysis 2013–2017 and Opportunity Assessment 2018–2028, By Drug Type

  7. North America Endometriosis Treatment Market size (US$ Mn) Analysis 2013–2017 and Opportunity Assessment 2018–2028, By Treatment Type

  8. North America Endometriosis Treatment Market size (US$ Mn) Analysis 2013–2017 and Opportunity Assessment 2018–2028, By Distribution Channel

  9. Latin America Endometriosis Treatment Market size (US$ Mn) Analysis 2013–2017 and Opportunity Assessment 2018–2028, By Country

  10. Latin America Endometriosis Treatment Market size (US$ Mn) Analysis 2013–2017 and Opportunity Assessment 2018–2028, By Drug Type

  11. Latin America Endometriosis Treatment Market size (US$ Mn) Analysis 2013–2017 and Opportunity Assessment 2018–2028, By Treatment Type

  12. Latin America Endometriosis Treatment Market size (US$ Mn) Analysis 2013–2017 and Opportunity Assessment 2018–2028, By Distribution Channel

  13. Western Europe Endometriosis Treatment Market size (US$ Mn) Analysis 2013–2017 and Opportunity Assessment 2018–2028, By Country

  14. Western Europe Endometriosis Treatment Market size (US$ Mn) Analysis 2013–2017 and Opportunity Assessment 2018–2028, By Drug Type

  15. Western Europe Endometriosis Treatment Market size (US$ Mn) Analysis 2013–2017 and Opportunity Assessment 2018–2028, By Treatment Type

  16. Western Europe Endometriosis Treatment Market size (US$ Mn) Analysis 2013–2017 and Opportunity Assessment 2018–2028, By Distribution Channel

  17. Eastern Europe Endometriosis Treatment Market size (US$ Mn) Analysis 2013–2017 and Opportunity Assessment 2018–2028, By Country

  18. Eastern Europe Endometriosis Treatment Market size (US$ Mn) Analysis 2013–2017 and Opportunity Assessment 2018–2028, By Drug Type

  19. Eastern Europe Endometriosis Treatment Market size (US$ Mn) Analysis 2013–2017 and Opportunity Assessment 2018–2028, By Treatment Type

  20. Eastern Europe Endometriosis Treatment Market size (US$ Mn) Analysis 2013–2017 and Opportunity Assessment 2018–2028, By Distribution Channel

  21. APEC Endometriosis Treatment Market size (US$ Mn) Analysis 2013–2017 and Opportunity Assessment 2018–2028, By Country

  22. APEC Endometriosis Treatment Market size (US$ Mn) Analysis 2013–2017 and Opportunity Assessment 2018–2028, By Drug Type

  23. APEC Endometriosis Treatment Market size (US$ Mn) Analysis 2013–2017 and Opportunity Assessment 2018–2028, By Treatment Type

  24. APEC Endometriosis Treatment Market size (US$ Mn) Analysis 2013–2017 and Opportunity Assessment 2018–2028, By Distribution Channel

  25. China Endometriosis Treatment Market size (US$ Mn) Analysis 2013–2017 and Opportunity Assessment 2018–2028, By Drug Type

  26. China Endometriosis Treatment Market size (US$ Mn) Analysis 2013–2017 and Opportunity Assessment 2018–2028, By Treatment Type

  27. China Endometriosis Treatment Market size (US$ Mn) Analysis 2013–2017 and Opportunity Assessment 2018–2028, By Distribution Channel

  28. MEA Endometriosis Treatment Market size (US$ Mn) Analysis 2013–2017 and Opportunity Assessment 2018–2028, By Country

  29. MEA Endometriosis Treatment Market size (US$ Mn) Analysis 2013–2017 and Opportunity Assessment 2018–2028, By Drug Type

  30. MEA Endometriosis Treatment Market size (US$ Mn) Analysis 2013–2017 and Opportunity Assessment 2018–2028, By Treatment Type

  31. MEA Endometriosis Treatment Market size (US$ Mn) Analysis 2013–2017 and Opportunity Assessment 2018–2028, By Distribution Channel

  32. Global Endometriosis Treatment Market Analysis 2013–2017 and Opportunity Assessment 2018–2028, By Region

  33. Global Endometriosis Treatment Market size (US$ Mn) Analysis 2013–2017 and Opportunity Assessment 2018–2028, By Drug Type

  34. Global Endometriosis Treatment Market size (US$ Mn) Analysis 2013–2017 and Opportunity Assessment 2018–2028, By Treatment Type

  35. Global Endometriosis Treatment Market size (US$ Mn) Analysis 2013–2017 and Opportunity Assessment 2018–2028, By Distribution Channel

To Learn More About our Comprehensive Perspective on Endometriosis Treatment Drugs Prescription Analysis, Contact Us

Get in touch

Harish Tiwari

Global Head - Business Development

Pranay Mhaisekar

Client Partner - Global Business Development

* indicates mandatory fields

Our Clients


CASE STUDIES

See how our work makes an impact.

At FMI, we design strategies that are adaptive, impactful, and implementable.

Request Sample Ask An Analyst Request Methodology